Source: Annual Congress 2006 - Therapy in childhood asthma I
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. M. Ducharme, S. Resendes, X. Zhang, H. D. Ochs, M. Bruce (Montreal, Canada; Seattle, United States Of America). Does a short course of oral glucocorticoids interfere with immune response in children with acute asthma?. Eur Respir J 2006; 28: Suppl. 50, 4078

Member's Comments

No comment yet.

Related content which might interest you: Airway autoimmunity and response to a 14-day course of oral corticosteroids in patients with severe eosinophilic asthma Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 Investigation of the very early immune response in viral induced experimental asthma exacerbation Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Is GLCCI1 associated with response to inhaled corticosteroids in asthma patients? Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Impact of acute active and passive stress on physiological responses in adults with asthma Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Comparison of the effect of short course of oral prednisone in patients with moderate and severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Postnatal immune response of high-risk children for development of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 144s Year: 2002 Characteristics of paediatric difficult asthma and systemic corticosteroid responsiveness Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003 Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study Source: International Congress 2017 – Monitoring asthma control Year: 2017 Is the timing of BCG administration important in the immunemodulation of lung allergic response? Source: Annual Congress 2004 - Modulation of the allergic response in animal models Year: 2004 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Effect of inhaled steroids on long term prognosis of lung function in adults with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 664s Year: 2004 Recognising the long-term burden of short course oral corticosteroids Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Do different vaccination regimens for BCG and hepatitis B affect the development of allergic disorders in early childhood? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses. Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019